Antidepressant effects of C-Terminal domain of the heavy chain of tetanus toxin in a rat model of depression

Behav Brain Res. 2019 Sep 16:370:111968. doi: 10.1016/j.bbr.2019.111968. Epub 2019 May 22.

Abstract

The C-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) may be of therapeutic potential in motor impairments associated with Parkinson disease (PD). Since depression is a common co-morbid condition with PD, we undertook this study to determine whether Hc-TeTx might also show antidepressant-like properties and whether central brain-derived neurotrophic factor (BDNF) and/or tumor necrosis factor (TNF)-alpha are also affected by it. Adult male Wistar-Kyoto rats, a putative animal model of depression, were treated with various doses of Hc-TeTx (0, 20, 40 and 60 μg/kg, IM) and their performance in the open field locomotor activity (OFLA) as well as in the forced swim test (FST) was evaluated at 24 h, one week and two weeks after the single injection. A separate group of rats were injected with 60 μg/kg Hc-TeTx and sacrificed 24 h later for neurochemical evaluations. Hc-TeTx resulted in a dose-dependent decrease in immobility score after 24 h, whereas OFLA was not affected. Concomitant with the 24 h behavioral effects, the levels of hippocampal and frontal cortical BDNF were significantly increased, whereas the levels of TNF-alpha in both these areas were significantly decreased. The decrease in immobility scores following higher doses of Hc-TeTx were still evident after one week, but not 2 weeks of rest. These results indicate long lasting antidepressant effects of a single Hc-TeTx dose and suggest potential utility of Hc-TeTx in PD-depression co-morbidity.

Keywords: BDNF; Forced swim test; Frontal cortex; Helplessness; Hippocampus; Parkinson’s disease; TNF-alpha.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Brain / drug effects
  • Corpus Striatum / drug effects
  • Depression / drug therapy*
  • Depression / metabolism
  • Depressive Disorder / drug therapy
  • Disease Models, Animal
  • Hippocampus / drug effects
  • Locomotion / drug effects
  • Male
  • Motor Activity / drug effects
  • Neuroprotective Agents / pharmacology
  • Parkinson Disease / drug therapy
  • Peptide Fragments / metabolism
  • Peptide Fragments / pharmacology*
  • Rats
  • Rats, Inbred WKY
  • Tetanus Toxin / metabolism
  • Tetanus Toxin / pharmacology*

Substances

  • Antidepressive Agents
  • Neuroprotective Agents
  • Peptide Fragments
  • Tetanus Toxin
  • tetanus toxin fragment C